Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer
Authors:
- 8 March 2023
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 84 (3) , 275-286
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP180725)
- National Institutes of Health (CPRIT RP190208)
- American Cancer Society (RSG-16-004-01-CCE)
- National Cancer Institute (1R01CA258584, 5P30CA142543, 5RO1CA154475, P50CA196516, U01CA207091)
This publication has 47 references indexed in Scilit:
- Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinomaJournal of Neurosurgery: Spine, 2012
- Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Ablative therapies for renal tumorsTherapeutic Advances in Urology, 2010
- The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and DepthJournal of Urology, 2009
- Cryoablation or radiofrequency ablation of the small renal massCancer, 2008
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Efficacy of Ablative High-Dose-per-Fraction Radiation for Implanted Human Renal Cell Cancer in a Nude Mouse ModelEuropean Urology, 2006
- The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World LiteratureJournal of Urology, 2006
- A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinomaActa Oncologica, 2006
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997